Lidocaine HCl 4 Percent

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Lidocaine HCl 4 Percent
Generic name: LIDOCAINE HYDROCHLORIDE
Manufacturer: ARI BRANDS, LLC
Product type: HUMAN OTC DRUG
SPL set ID: 81aff5c5-91c0-4173-a432-d20115613580
SPL ID: 0155a80c-5814-4cea-9dc3-3b56164690a4
Version: 1
Effective date: 2024-04-30
Source export date: 2026-10-12
Source partition: 5
Source file: https://download.open.fda.gov/drug/label/drug-label-0005-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-12/13cbfcd236c665f0ee69e2d9141331148dcdff45d1679c92f029cfba27dd74a2/drug-label-0005-of-0014.json.zip
Source manifest SHA-256: 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run: 20261013T011858Z
Imported at: 2026-10-13 01:43:42

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M017	openfda.application_number
brand name		Lidocaine HCl 4 Percent	openfda.brand_name
generic name		LIDOCAINE HYDROCHLORIDE	openfda.generic_name
manufacturer name		ARI BRANDS, LLC	openfda.manufacturer_name
ndc	package	71436-0026-1	openfda.package_ndc
ndc	product	71436-0026	openfda.product_ndc
ndc11	package	71436002601	derived:openfda.package_ndc
rxcui		1010895	openfda.rxcui
spl id		0155a80c-5814-4cea-9dc3-3b56164690a4	id
spl set id		81aff5c5-91c0-4173-a432-d20115613580	set_id
unii		V13007Z41A	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only. When using this product Avoid contact with the eyes D o not use in large quantities, particularly over raw surfaces or blistered areas Stop use and ask a doctor If condition worsens, or if symptoms persist for more than 7 days or clear up and occur again within a few days. If allergic reaction occurs or if redness, irritation, swelling, pain or other symptoms begin or increase. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.